Lutz Lingnau's most recent trade in Nektar Therapeutics was a trade of 18,200 Stock Option done . Disclosure was reported to the exchange on Sept. 22, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nektar Therapeutics | Lutz Lingnau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 18,200 | 18,200 | - | - | Stock Option | |
| Nektar Therapeutics | Lutz Lingnau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 9,100 | 35,800 (0%) | 0% | 0 | Common Stock |